Clinical validation of the CD32b biomarker on the European market

Carol Prives

Properties and Regulation of p53 in Tumor Cells

Liver and intrahepatic bile ducts Leukaemia

Pathology

Clark W Distelhorst

Targeting PKM2-InsP3R interaction to treat AML

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies Pathology

David A Williams

Rac proteins in hematopoietic cell survival and function

Leukaemia

Hematology and hematologic malignancies

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Peter Inskip

International Consortium of Case-control Studies of Adult Brain Tumors (Brain Tumor Epidemiology Consortium)

Thyroid Leukaemia Brain, nervous system

Radiation Oncology

Matthew H Porteus

Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID

Leukaemia

Alejandro Gutierrez

Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL

Leukaemia

Jarrod A. Marto

Phosphoproteomic signatures for early detection and stratification of AML

Leukaemia